Theresa Kepic is categorized under Internal Medicine Doctors in North Chicago, IL and active since 2010.
Theresa Kepic was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Theresa A Kepic at the company’s single location by writing to 3471 Green Bay Road, North Chicago, Illinois IL 60064 or by phoning (847) 473-4357. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Theresa Kepic |
| Contact Person: | Theresa A Kepic |
| Address: | 3471 Green Bay Road, North Chicago, Illinois 60064 |
| Phone Number: | (847) 473-4357 |
| Website Address: | rosalindfranklin.edu |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Theresa Kepic was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Theresa A Kepic for inquiries that concern Theresa Kepic by calling the company number (847) 473-4357, as your correspondence is most welcome. Additionally, the physical location of the single location of Theresa Kepic can be found at the coordinates 42.297437,-87.860132 as well as the street address 3471 Green Bay Road in North Chicago, Illinois 60064.
For its online presence, you may visit Theresa Kepic’s website at rosalindfranklin.edu and engage with its social media outlets through on Twitter and on Facebook.